ClinicalTrials.gov
public full text
Public Domain
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
The Serpentine (Stratify cancER PatiENTs by ImmuNosupprEssion) project, represents the most consistent effort so far attempted to translate MDSC into clinical practise by producing an off-the-shelf compliant assay for quantifying these cells in peripheral blood.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Micro Assays for HemATology Malignancies Antibody Treatment#1103003
- Early Response Evaluation in NSCLC Patients Treated With Immunotherapy#992271
- Immune Profiling for Cancer Immunotherapy Response#373605
- Quantifying Systemic Immunosuppression to Personalize Cancer Therapy#851374
- Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors#812426
Record · ID 861951
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive